Your browser doesn't support javascript.
loading
The Human Leukocyte Antigen-DPB1 Degree of Compatibility Is Determined by Its Expression Level and Mismatch Permissiveness: A German Multicenter Analysis.
Mytilineos, Daphne; Tsamadou, Chrysanthi; Neuchel, Christine; Platzbecker, Uwe; Bunjes, Donald; Schub, Natalie; Wagner-Drouet, Eva; Wulf, Gerald; Kröger, Nicolaus; Murawski, Niels; Einsele, Hermann; Schaefer-Eckart, Kerstin; Freitag, Sebastian; Casper, Jochen; Kaufmann, Martin; Dürholt, Mareike; Hertenstein, Bernd; Klein, Stefan; Ringhoffer, Mark; Mueller, Carlheinz R; Frank, Sandra; Schrezenmeier, Hubert; Fuerst, Daniel; Mytilineos, Joannis.
Afiliación
  • Mytilineos D; Institute of Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Transfusion Service, Baden Wuerttemberg-Hessen, and University Hospital Ulm, Ulm, Germany.
  • Tsamadou C; Institute of Transfusion Medicine, University of Ulm, Ulm, Germany.
  • Neuchel C; Department of Otorhinolaryngology, Head and Neck Surgery, University of Ulm, Ulm, Germany.
  • Platzbecker U; Institute of Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Transfusion Service, Baden Wuerttemberg-Hessen, and University Hospital Ulm, Ulm, Germany.
  • Bunjes D; Institute of Transfusion Medicine, University of Ulm, Ulm, Germany.
  • Schub N; Institute of Clinical Transfusion Medicine and Immunogenetics Ulm, German Red Cross Blood Transfusion Service, Baden Wuerttemberg-Hessen, and University Hospital Ulm, Ulm, Germany.
  • Wagner-Drouet E; Institute of Transfusion Medicine, University of Ulm, Ulm, Germany.
  • Wulf G; Department of Hematology/Oncology, University of Leipzig, Leipzig, Germany.
  • Kröger N; Department of Internal Medicine III, University of Ulm, Ulm, Germany.
  • Murawski N; Division of Stem Cell Transplantation and Immunotherapy, 2nd Department of Medicine, University of Kiel, Kiel, Germany.
  • Einsele H; Department of Medicine III, Johannes Gutenberg-University Mainz, Mainz, Germany.
  • Schaefer-Eckart K; Department of Hematology/Oncology, Georg-August-University Göttingen, Göttingen, Germany.
  • Freitag S; Department of Stem Cell Transplantation, University Hospital Hamburg Eppendorf, Hamburg, Germany.
  • Casper J; Department Internal Medicine I, Universitätsklinikum des Saarlandes, Homburg, Germany.
  • Kaufmann M; Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany.
  • Dürholt M; Medizinische Klinik 5, Klinikum Nürnberg, Paracelsus Medizinische Privatuniversität, Nürnberg, Germany.
  • Hertenstein B; Department of Medicine III, Hematology/Oncology/Palliative Care, Rostock University Medical Center, Rostock, Germany.
  • Klein S; Division of Hematology and Oncology, Oldenburg Clinic, University of Oldenburg, Oldenburg, Germany.
  • Ringhoffer M; 2nd Department of Internal Medicine, Oncology and Hematology, Robert Bosch Hospital Stuttgart, Stuttgart, Germany.
  • Mueller CR; Department of Hematology/Oncology and Stem Cell Transplantation, Evangelisches Krankenhaus Essen-Werden, Essen, Germany.
  • Frank S; Department of Hematology/Oncology, Klinikum Bremen-Mitte, Bremen, Germany.
  • Schrezenmeier H; Medizinische Klinik III, Universitäts Medizin Mannheim, Mannheim, Germany.
  • Fuerst D; Medizinische Klinik III, Städtisches Klinikum Karlsruhe, Karlsruhe, Germany.
  • Mytilineos J; ZKRD - Zentrales Knochenmarkspender-Register für Deutschland, German National Bone Marrow Donor Registry, Ulm, Germany.
Front Immunol ; 11: 614976, 2020.
Article en En | MEDLINE | ID: mdl-33569061
T-cell epitope matching according to the TCE3 algorithm classifies HLA-DPB1 mismatches in permissive and non-permissive. This classification has been shown to be predictive for mortality and acute GvHD (aGvHD) events in large international cohorts. We retrospectively genotyped HLA-DPB1 in 3523 patients transplanted in Germany between 2000 and 2014 and in their unrelated donors using an Illumina amplicon-NGS based assay. Aim of the study was to evaluate DP-compatibility beyond the established TCE3 algorithm by assessing the combined effect of several DP-mismatch parameters on post-transplant outcome. We implemented an extended DP-mismatch assessment model where TCE3, DP allotype expression with respect to rs9277534, mismatch vector and number of mismatches were conjointly taken into consideration. In this model, non-permissive HLA-DPB1 mismatches showed significantly increased aGvHD risk if they were accompanied by two HLA-DPB1 mismatches in GvH direction (HR: 1.46) or one mismatched highly expressed patient allotype (HR: 1.53). As previously reported, non-permissive HLA-DPB1 mismatches associated with a significantly higher risk of aGvHD and non-relapse mortality (HR 1.36 and 1.21, respectively), which in turn translated into worse GvHD and relapse free survival (HR 1.13). Effects on GvL and GvHD appeared strongest in GvH-directed non-permissive mismatches. Our study results support the consideration of additional HLA-DPB1 mismatch parameters along with the established TCE3 matching algorithm for refinement of future donor selection. In particular, our findings suggest that DP non-permissiveness associated with two HLA-DPB1 mismatches or at least on highly expressed mismatched patient allotype should be avoided.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante de Médula Ósea / Modelos Inmunológicos / Epítopos de Linfocito T / Trasplante de Células Madre de Sangre Periférica / Cadenas beta de HLA-DP / Enfermedad Injerto contra Huésped / Histocompatibilidad Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Front Immunol Año: 2020 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante de Médula Ósea / Modelos Inmunológicos / Epítopos de Linfocito T / Trasplante de Células Madre de Sangre Periférica / Cadenas beta de HLA-DP / Enfermedad Injerto contra Huésped / Histocompatibilidad Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Infant / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Front Immunol Año: 2020 Tipo del documento: Article País de afiliación: Alemania